Home Applications 215880 Application 215880
Type ANDA
Sponsor MANKIND PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE;ORAL EQ 40MG BASE No No 002 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215880-001 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 A215880-002 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL 2024-04-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A215880-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 48 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 e64feba35796…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215880-001 PANTOPRAZOLE SODIUM EQ 40MG BASE TABLET, DELAYED RELEASE / ORAL AB 2022-07-26 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215880-002 PANTOPRAZOLE SODIUM EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL 2024-04-25 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 1 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 70756-019 Pantoprazole sodium delayed-release Pantoprazole sodium delayed-release Lifestar Pharma LLC ANDA Current